Thoughts on God’s word (letter) – York Daily Record
By Dr. Matthew Watson
Thoughts on God's word (letter) York Daily Record The essential meaning of this revelation is contradicted by Darwin's hypothesis, which is itself lamentably deficient in evidence, and now contradicted by molecular genetics. Moreover, the symbolism of the image of God in the sexual union of man and ... |
Revealed: how exam results owe more to genes than teaching – Spectator.co.uk
By Dr. Matthew Watson
Spectator.co.uk | Revealed: how exam results owe more to genes than teaching Spectator.co.uk It's no surprise really, to find out towards the end of our conversation that Plomin is not just at the cutting edge of behavioural genetics, but also at the heart of molecular genetics as well. Remember that Chinese programme I mentioned? It turns out ... |
Onslaught of Autism: A Mom’s Crusade Could Help Unravel Scientific Mystery – Jackson Free Press
By Dr. Matthew Watson
Onslaught of Autism: A Mom's Crusade Could Help Unravel Scientific Mystery Jackson Free Press For the majority of patients we know something else is going on, and that might be epigenetic changes," said Emilie Rissman, professor of biochemistry and molecular genetics at the University of Virginia School of Medicine. Many diseases have increased ... |
Party people they are not – The Australian
By Dr. Matthew Watson
Party people they are not The Australian In 2009, at age 19, he received his PhD in molecular genetics and cell biology from the University of Chicago, which then awarded him a MD a year later. But the youngest ever PhD is believed to be Karl Witte, who was awarded a doctorate in philosophy ... |
California Stem Cell Official Duane Roth in Improving Condition
By Dr. Matthew Watson
California stem cell agency, is improving after he was hospitalized
for treatment of a serious brain injury sustained in a bicycle accident Sunday in
the mountains east of San Diego.
Roth's brother, Ted, said yesterday,
“Were certainly moving in the
right direction. We're now looking at the recovery phase.”
has passed through the most critical period following surgery at the
UC San Diego hospital.
Diego technology organization, Connect, is in serious condition in a
medically induced coma.
stem cell agency yesterday took special note of Roth at its meeting and sent its best wishes to him and his family.
Another $23 Million to Recruit Star Stem Cell Scientists to California
By Dr. Matthew Watson
stem cell research stars to the Golden State was expanded today by
another $23 million.
approved the funds on a 14-4-1 vote. CIRM directors Jeff Sheehy and
Francisco Prieto were among those opposing the move. Prieto declared,
“We are coming up against finite resources. We have better ways to spend
our money."
Sheehy said that CIRM is contributing to inflation in stem cell science with its lucrative recruitment grants.
institutions that have not already benefited from one of the earlier
grants in the program. Up to four awards are expected to be made.
said,
“A number of California institutions
have not yet been able to secure a confirmed Research Leadership
award but would benefit greatly from the recruitment of emerging or
established leaders in stem cell biology. Participation in the CIRM
program could bring additional, exceptional researchers to
California, strengthen and synergize with other efforts to build up
local sustained research communities in stem cell biology and
medicine and provide ongoing leadership at the cutting edge of
California regenerative medicine.”
involved with the winning researchers have representatives on the
governing board of the stem cell agency. They are not allowed, however, to vote
on grants to their institutions or researchers -- only on proposals such as today's $23 expansion.
final approval scheduled for next May. The program is not open to
businesses.
California Stem Cell Agency Launches $70 Million Alpha Stem Cell Clinic Project
By Dr. Matthew Watson
The California stem cell agency today approved
a $70 million plan to create a network of “Alpha” stem cell
clinics that is aimed at making the Golden State one of the leading
purveyors and developers of stem cell therapies in the world.
Institute for Regenerative Medicine (CIRM)adopted the plan on a 19-1 vote. The negative vote came from Joan Samuelson, who questioned
whether the plan was premature and whether existing scientific research justified development of the clinics.
former head of a Hollywood studio, said the proposal is “one of the
most exciting proposals that we have ever had in front of us.” She
said it was the “beginning of this dream coming true.”
CIRM President Alan Trounson has been promoting for two years, the
agency will finance five stem cell clinics at established
institutions in California with grants of up to $11 million. Another
$15 million will be allotted for a stem cell information and
coordination center. Major matching contributions will be expected
from award winners over the five-year terms of the grants.
clinical trials and patients from the around the world and creating a
central bank of knowledge, know-how and regulatory expertise. It
will also guide efforts to build profits into stem cell therapies
and to develop strategies to attract investors and philanthropists.
(For more information on the plan, see here, here, here, here and
here.)
“These clinics have the potential to
revolutionize how we deliver stem cell therapies to patients. Stem
cell therapies are a completely new way of treating diseases and
disorders so we need a completely new way of delivering those in a
safe and effective manner. These clinics will help us do just that
and the clinical trials carried out in this network will fulfill the
agency’s promise of bringing new therapies to patients who need
them.”
reported that the Alpha clinics would be the first-ever “clinical
trials network focused around a broad therapeutic platform.”
comment on the plan other than the remarks by Samuelson. . However,
not everyone sees a need for it. Mahendra Rao, director of the Center
for Regenerative Medicine at the National Institutes of
Health(NIH) , says its surveys of researchers have not shown a demand
for such centers. In May, a researcher at institution that likely
would be an applicant filed a blistering, anonymous comment on the
California Stem Cell Report, describing it as a "boondoggle" and "irresponsible." The scientist said,
“Another boondoggle for some medical
schools but made to order for private operators like for-profit
cancer, dialysis, and laser eye specialty clinics that do one
procedure. I can see each of the medical schools gifted with
one as they each were gifted with about 25 million dollars for stem
cell institute buildings.”
“The NIH at various times has tried
to organize clinical trials groups with infrastructure, like quick
reaction forces, ready to gear up for a new trial at the drop of a
hat. They mainly did nothing but suck money, kept staff employed,
because there are generally few drugs ready for early human trials
and each treatment that is brought along requires a unique contract,
ethics reviews, and different facilities, equipment and staff than
planned for. The latest incarnation are CTSAs or CTSIs,
clinical and translational science centers funded by the federal NIH
that most if not all California medical schools already have.”
go out in October and approval of funding coming one year from now. Here is the link to today's CIRM press release on the plan.
Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/EBbBzLL9dQQ/california-stem-cell-launches-70.html
Coming Up: Live Coverage of Today’s California Stem Cell Meeting
By Dr. Matthew Watson
provide live, wall-to-wall coverage of today's meeting of the
governing board of the $3 billion California stem cell agency.
million proposal aimed at creating a string of Alpha stem cell clinics in
California that would serve as a foundation for the state's stem cell
business. Also on tap are other proposed grant programs, including a
$23 million expansion of a researcher recruitment effort and a $35 million round aimed at removing roadblocks to turning research into
cures.
throughout the day based on the Internet audiocast of the proceedings.
on the meeting via the Internet. Instructions can be found on the agenda.
Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/Vi8IGlL2TzY/coming-up-live-coverage-of-todays.html
Stem Cell Lines and Paid-for Eggs: Stem Cell Agency Delays Action on Easing Restrictions
By Dr. Matthew Watson
agency today balked at approving a plan to ease restrictions on
using stem cell lines derived from women who were paid for their
eggs.
taken up tomorrow by the governing board of the $3 billion agency,
but the board's standards working group delayed action.
McCormack, a spokesman for the agency, said in an email,
“It was felt that more discussion
was needed before moving to a vote so another meeting is going to be
scheduled.”
approved regulations that banned the use of CIRM funds for stem cells
lines derived using compensation. That rule would be modified under
today's plan, which would permit the CIRM governing board to approve
the use of such lines following a staff study evaluating scientific and ethical issues.
Their use would be allowed if the lines would “advance CIRM's
mission.”
The delay came after four
organizations, including the Center for Genetics and Society in
Berkeley, argued that the plan is vague and did not adequately
address safety issues.
said that the plan does not appear to have met “numerous concerns”
raised in 2009 in a document co-authored by the CIRM staff. Those
concerns include long-term risk and ethical issues.
that the agency governing board
“...will decide whether to approve a
grantee’s request to use a stem cell line created with paid-for
eggs on the basis of whether doing so 'will advance CIRM’s
mission.' This criterion is much too vague, and doesn’t include
consideration of the health or welfare of the women who undergo egg
retrieval. Protecting the well-being of women providing eggs is not
even mentioned (though perhaps it could be considered as an element
of the fifth of five 'factors to be considered by the ICOC(the agency
board),' 'whether the donation…was consistent with `best practices’
at the time of donation').”
The standards group also heard from a
UCLA researcher who argued on behalf of the change. Kathrin Plath
said she and her colleagues wanted to use a paid-for stem cell line
from the Oregon experiment that cloned human stem cells.
the four organizations.
$70 Million Alpha Stem Cell Clinic Project Garners Mainstream Media Attention
By Dr. Matthew Watson
chain of “Alpha” stem cell clinics today received its first major
attention from the mainstream media.
circulation newspaper, appearing this morning on the home page of the
website of Los Angeles Times.
around the state and a coordination/information center under a
concept that comes before the governing board of the state's $3
billion stem cell agency at its meeting tomorrow in Burlingame, Ca. Funds could be
awarded as early as a year from now. (For more information, see here
and here.)
DeWitt, special projects officer for CIRM, as the stem cell agency is known, and Maria Millan, a CIRM
medical officer. Brown wrote,
“Clinics to conduct trials of stem
cell therapies have different needs than clinics designed to deliver
conventional therapies, DeWitt and Millan said. They need special
facilities for handling the cells safely, as well as imaging
equipment to track the cells once they're delivered into a patient’s
body. Some of this infrastructure already exists, but other
parts of it still need to be perfected. Establishing clinics to
house multiple trials might create the critical mass needed to get
the infrastructure in place, they said....
"Additionally, they said, CIRM
hopes that such collaboration would encourage stem cell companies to
share information -- speeding their own work and also helping out
policymakers and insurers who are trying to figure out how they'll
pay for stem cell therapies in the future.”
California Stem Cell Report as saying last week,
“The Alpha clinics
are aimed at creation of a sturdy foundation for the stem cell
industry in California, capitalizing on the burgeoning, international
lure of stem cell treatments.”
clinics at major, established institutions around the state. It is
possible that two could be located in the Los Angeles area at
institutions such as UCLA, USC, Cedars-Sinai or the City of Hope, all
of which have representatives on the stem cell agency's governing
board. Other likely locations are in the San Francisco Bay area and
San Diego, again at facilities such as Stanford, UC San Francisco and
UC San Diego that have representation on the agency board.
including businesses, will be subject to closed-door. peer review
prior to final action by the full governing board.
Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/s_-mm4nTU_0/70-million-alpha-stem-cell-clinic.html
UCLA Researcher Calls for Easing of Restrictions on Stem Cell Lines Derived from Eggs From Paid Providers
By Dr. Matthew Watson
support of a proposal to allow use of California stem cell agency
funds to purchase stem cell lines derived from eggs provided by women
who have been paid for the service.
experiment by Shoukhrat Mitalipov in which human stem cells were cloned. Currently agency funds cannot be used for that purpose as
a result of regulations that are the extension of a state law that
bars use of agency funds for payment for eggs.
then go before the full board tomorrow.
“In my lab, we are ... interested in
understanding what happens to the somatically silenced X chromosome
when differentiated cells are reprogrammed by SCNT. The key question
is: are these SCNT-ESCs more similar to iPSCs or
fertilization-derived ESCs with respect to the epigenetic state of
the X chromosome. Furthermore, it has been shown in mouse
reprogramming that the active X chromosome becomes deregulated during
SCNT-based reprogramming, and we would like to address this problem
in the human system as well.
“We believe that the comparison of
the epigenetic states between fertilization-derived ESCs, SCNT-ESCs
and human iPSCs is important for a better characterization of these
cells and understanding of their epigenetic nature.”
‘Frankenstein’s Cat’ poses ethical questions about biotechnology – South China Morning Post
By Dr. Matthew Watson
'Frankenstein's Cat' poses ethical questions about biotechnology South China Morning Post Here's a cheery fact: between acts of war and more diabetes, the number of human amputees is expected to grow around 40 percent by 2020. This I learned from Frankenstein's Cat: Cuddling Up to Biotech's Brave New Beasts by Emily Anthes, a book I picked ... |
FAQ4 A Scientific Basis for Stem Cell Therapy – Video
By Dr. Matthew Watson
FAQ4 A Scientific Basis for Stem Cell Therapy
http://youtu.be/uf_toA9Nzuo With all the hype online and in the media today, it is easy to believe that Stem Cell therapy is ALSO #39;hype #39;, but it actually eme...
By: Kerry Dean
Go here to read the rest:
FAQ4 A Scientific Basis for Stem Cell Therapy - Video
Oklahoma Veterinarian Offering Stem Cell Therapy For Aging Pets
By Sykes24Tracey
TULSA, Oklahoma -
A controversial therapy that's not available for humans is being used on their pets. Stem cells are helping dogs and cats heal faster and get rid of pain as the animals get older.
Mandy Clinton loves her dog and she'd do just about anything for her.
"I've had her for 14 years. She's my homegirl," Clinton said about Libbi.
But Libbi has come up with a hitch in her giddy up. She tripped while walking up the stairs and tore her ACL.
Clinton was looking into surgery when she learned about stem cell therapy and its ability to help dogs heal faster and reduce pain.
"I had no idea. I had no idea. It blew my mind, but I've had Libbi for 14 years, and so I was ready to do it if it was possible," she said.
Dr. Joe Landers at Heritage Veterinary Hospital will be performing Libbi's surgery on Wednesday.
They'll harvest stem cells from Libbi's stomach, process and stimulate them, then implant the stem cells on her leg joint.
"If you've ever cut your skin, deeply with a knife or something, you've had stem cell repair," said Dr. Joe Landers, DVM.
Read more from the original source:
Oklahoma Veterinarian Offering Stem Cell Therapy For Aging Pets
Stem Cell Therapy Used as Dog Arthritis Treatment – Video
By Dr. Matthew Watson
Stem Cell Therapy Used as Dog Arthritis Treatment
We have dedicated our careers to helping dogs live to the fullest extent possible. For more information please visit one of our articles below: Dog Arthritis...
By: Duncan Bulow
See the original post:
Stem Cell Therapy Used as Dog Arthritis Treatment - Video
Arthritis Treatment Center What is Stem Cell Therapy – Video
By raymumme
Arthritis Treatment Center What is Stem Cell Therapy
http://www.arthritistreatmentcenter.com/what_stem_cell.html - This facts will truly surprise you and your family.
By: Joseph Richardson
Read the original post:
Arthritis Treatment Center What is Stem Cell Therapy - Video
Stem Cell Orthopedic Applauds Use of Stem Cell Therapy for Spinal Injuries
By JoanneRUSSELL25
(PRWEB) July 22, 2013
The Institute of Regenerative and Molecular Orthopaedics (IRMO), world-renowned stem cell therapy experts, applauds the use of stem cell therapy for treatment of spinal injuries. In recent times, stem cell therapy has been increasingly sought after to support treatments of various injuries, especially in the sports world. Its use in repairing spinal injuries comes as good news to the thousands of Americans currently living with spinal cord injuries who are seeking the latest in breakthrough medical solutions.
Stem cell therapy is of the most exciting and promising treatments in modern medicine. Inroads are made every day, as the many applications of stem cell treatments become better understood by medical professionals around the world. Experts, like Dr. Joseph Purita of the Institute of Regenerative and Molecular Orthopaedics, have been utilizing stem cell treatments for many years to treat sports injuries.
Recent scientific and technological advancements have made stem cell extraction relatively inexpensive and accessible. Today, medical professionals have unprecedented access to these remarkable cells and are increasingly applying them in new ways to better aid in the bodys repair process. This includes advances in platelet rich plasma therapy (PRP), a process that takes a concentration of a persons own plasma and injects it into areas in need of new growth and tissue repair.
The use of stem cell therapy in the treatment of spinal cord injuries presents probably the biggest challenge yet for proponents of the treatment. Researchers are increasingly using stem cells to hopefully better understand its capabilities. The hope for spinal cord injuries is that one day stem cells can be used to generate new passageways for nerve signals to connect to muscles. The more stem cells are used for treatment in spinal cord injuries, the closer the medical field will be to fulfilling this promise.
Headed by the world-renowned stem cell treatment pioneer, Dr. Purita, the Institute of Regenerative and Molecular Orthopaedics is continually advancing the world of stem cell therapy treatments. They are one of the few orthopedic practices in existence that utilizes stem cell therapy, and PRP therapy, with orthopedic surgery to maximize a patients recovery outcome. As more stem cell treatments are being used to treat spinal injuries, Dr. Purita and his group look forward to seeing what great strides are made in battling the crippling condition in the near future.
About Stem Cell Orthopedic: The Institute of Regenerative and Molecular Orthopaedics (IRMO) is a world-class orthopedic practice and stem cell facility staffed with seasoned board certified orthopedic surgeons. They differ from most orthopedic practices because they offer stem cells and platelet rich plasma (PRP) therapy in conjunction with surgery or as alternative to surgical procedures. They utilize state-of-the-art technology and the latest in stem cell research to best treat their patients. IRMO uses hematopoietic stem cells (HSC), which are found circulating in blood, fat, and bone marrow, to help repair the body. They are headed by Medical Director, Dr. Joseph Purita, a world-renowned pioneer in laser orthopedic surgery and graduate of the esteemed Georgetown University Medical School. For more information, visit http://www.stemcellorthopedic.com/ or follow them on Facebook, Twitter, or YouTube.
See the original post:
Stem Cell Orthopedic Applauds Use of Stem Cell Therapy for Spinal Injuries
De Leon: Medical Tourism and the Future of Stem Cell Therapy (Part 2)
By raymumme
LAST week, we discussed the potential of medical tourism in the country which will also provide opportunities for destinations like Baguio once tapped, and subject to competitive and international standards and government/ regulatory requirements.
So much has been written and reported about Stem Cell Therapy including its extraordinary promises that research holds for the treatment of a wide range of diseases and conditions.
This week, lets delve deeper.
What is Stem Cell Therapy?
Cell Therapy has been interchangeably called many names such as cellular therapy, fresh cell therapy, live cell therapy, glandular therapy, or xenograph or xenotransplant therapy.
The International Society for Stem Cell Research (ISSCR) describes stem cell therapy as a treatment that uses stem cells, or cells that come from stem cells, to replace or to repair a patients cells or tissues that are damaged. The stem cells might be put into the blood, or transplanted into the damaged tissue directly, or even recruited from the patients own tissues for self-repair.
Stem Cells have been differentiated based on where in the body or what stage in development they come from. ISCCR has enumerated them as follows (source:www.isscr.org):
1. Adult Stem Cells or Tissue-specific Stem Cells. Many adult tissues contain stem cells that can replace cells that die or restore tissue after injury. Skin, muscle, intestine and bone marrow, for example, each contain their own stem cells. In the bone marrow, billions of new blood cells are made every day from blood-forming stem cells. Adult stem cells are tissue-specific, meaning they are found in a given tissue in our bodies and generate the mature cell types within that particular tissue or organ. It is not clear whether all organs, such as the heart, contain stem cells. The term adult stem cells is often used very broadly and may include fetal and cord blood stem cells.
Another type of adult stem cell is the mesenchymal stem cell. These are found in a number of tissues, including bone marrow, and may be able to produce bone, cartilage and fat. It is also possible that these or similar cells may aid in the regeneration of tissues. Extensive animal studies are currently ongoing to determine if these cells may be used for treatment of diseases such as arthritis and non-healing bone fractures. It is also possible that these or similar cells modulate the immune system in response to injury.
2. Fetal Stem Cells. Fetal stem cells are taken from the fetus. The developing baby is referred to as a fetus from approximately 10 weeks of gestation. Most tissues in a fetus contain stem cells that drive the rapid growth and development of the organs. Like adult stem cells, fetal stem cells are generally tissue-specific, and generate the mature cell types within the particular tissue or organ in which they are found.
Go here to see the original:
De Leon: Medical Tourism and the Future of Stem Cell Therapy (Part 2)
‘The results are profound’; Stem cell therapy used to treat animal ailments – Video
By Sykes24Tracey
#39;The results are profound #39;; Stem cell therapy used to treat animal ailments
#39;The results are profound #39;; Stem cell therapy used to treat animal ailments.
By: kgun9
Read more:
'The results are profound'; Stem cell therapy used to treat animal ailments - Video
FAQ1-Stem Cell Therapy – Video
By Sykes24Tracey
FAQ1-Stem Cell Therapy
http://youtu.be/dJHlHBrmvrU Stem cell therapy has earned global fame for its proven ability to help sufferers of many diseases, with little ill effects or si...
By: Kerry Dean
Read the rest here:
FAQ1-Stem Cell Therapy - Video